Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

21 May 2009

Advanced glycation end-products (ages) in transplanted heart pathology of patients with or without diabetes mellitus type 2 (DM)

M Zakliczyński, J Nożyński, D Konecka-Mrówka, B Nikiel, J Młynarczyk-Liszka, D Lange, M Zembala

Ann Transplant 2009; 14(1): 62-62 :: ID: 880423

Abstract

Background: Abnormal glycaemia in orthotopic heart transplant (OHT)
recipients may result in AGEs formation. However the role of AGEs in development of acute rejection (AR) and coronary vasculopathy (CAV) is unknown. The Aim of the study was to localize AGEs in endomyocardial biopsies (EMBs) in order to correlate their presence with AR and CAV in OHT
subjects with and without DM.
Material/Methods: Elective EMBs performed 3y post OHT in 65 pts. with DM (60M/5F, 49±8y/o) and 24pts. without DM (21M/3F, 42±10y/o) were involved in the study. Localization of AGEs in myocardial paraffin sections was assessed immunochemically using mouse monoclonal anti-AGE antibodies. The presence of AGEs in cardiomyocytes, stromal cells, connective tissue cells and capillaries was described with semi-quantitative scale.
Results: Occurrence of AGEs was similar in both groups - cardiocytes 74 vs.
63%, stroma 34 vs. 33%, connective tissue 14 vs. 9%, and capillaries 32vs.33% - in DM vs. non-DM pts., while intensity of staining was significantly higher in DM subjects. Overall number of AR episodes and mean EMB score were significantly correlated with AGE presence in cardiomyocytes (r=0.31/0.25, p=0.011/0.049, Spearman test), but only in DM group. There was no relation between AGEs and CAV in DM pts., while time free from any angiographically confirmed CAV, and CAV related event was significantly longer in non-DM pts. with AGEs in cardiomyocytes and/or capillaries (p=0.017/0.014/0.03/0.014 respectively, log-rank test).
Conclusions: AGEs occurrence in DM subjects is related to AR, but does not predict CAV, while in non-DM patients it is correlated with AR, but prolongs freedom from CAV.

Keywords: Heart Transplantation

Add Comment 0 Comments

In Press

12 Feb 2024 : Original article  

No Prognostic Impact of Graft-to-Recipient Weight Ratio on Hepatocellular Carcinoma Recurrence Following Li...

Ann Transplant In Press; DOI: 10.12659/AOT.942767  

21 Feb 2024 : Original article  

Use of LCP-Tacrolimus (LCPT) in Kidney Transplantation: A Delphi Consensus Survey of Expert Clinicians

Ann Transplant In Press; DOI: 10.12659/AOT.943498  

Most Viewed Current Articles

05 Apr 2022 : Original article  

Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver Transplantation

DOI :10.12659/AOT.935604

Ann Transplant 2022; 27:e935604

12 Jan 2022 : Original article  

Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...

DOI :10.12659/AOT.934738

Ann Transplant 2022; 27:e934738

22 Nov 2022 : Original article  

Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...

DOI :10.12659/AOT.937988

Ann Transplant 2022; 27:e937988

15 Mar 2022 : Case report  

Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...

DOI :10.12659/AOT.935860

Ann Transplant 2022; 27:e935860

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358